Fundación Respirar ( Site 0306)

Buenos Aires C1426ABP

0 studies enrolling now · 1 studies all time

What they study most

Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10) — Completed